The multifocal pattern electroretinogram in chloroquine retinopathy

Ophthalmic Research

Volumn 36, Issue 2, 2004, Pages 106-113

  Neubauer, Aljoscha S ^a   Stiefelmeyer, Sandra ^a   Berninger, Thomas ^a   Arden, Geoffrey B ^b   Rudolph, Günther ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b CITY UNIVERSITY   (United Kingdom)

Author keywords

Antimalarial toxicity; Electrophysiology; Multifocal pattern electroretinogram; Screening

Indexed keywords

CHLOROQUINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COLOR VISION DEFECT; COLOR VISION TEST; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; EYE TOXICITY; FEMALE; HUMAN; LATENT PERIOD; LONG TERM EXPOSURE; PERIMETRY; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINOPATHY; RHEUMATOID ARTHRITIS; SCOTOMA; VISUAL FIELD;

ADULT; AGED; ANTIMALARIALS; CHLOROQUINE; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; ELECTRORETINOGRAPHY; HUMANS; MIDDLE AGED; PERIMETRY; RETINA; RETINAL DISEASES; SCOTOMA; VISION SCREENING; VISUAL FIELDS;

EID: 1842457074     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076890     Document Type: Article

References (62)

1. Cruess AF, Schachat AP, Nicholl J, Augsburger JJ: Chloroquine retinopathy: Is fluorescein angiography necessary? Ophthalmology 1985;92:1127-1129.
2. Easterbrook M: The use of Amsler grids in early chloroquine retinopathy. Ophthalmology 1984;91:1368-1372.
3. Hart WM Jr, Burde RM, Johnston GP, Drews RC: Static perimetry in chloroquine retinopathy: Perifoveal patterns of visual field depression. Arch Ophthalmol 1984;102:377-380.
4. Easterbrook M, Trope G: Value of Humphrey perimetry in the detection of early chloroquine retinopathy. Lens Eye Toxic Res 1989;6:255-268.
5. Marmor MF, Carr RE, Easterbrook M, et al: Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the American Academy of Ophthalmology. Ophthalmology 2002;109:1377-1382.
6. Vu BL, Easterbrook M, Hovis JK: Detection of color vision defects in chloroquine retinopathy. Ophthalmology 1999;106:1799-1803;discussion 804.
7. Kolb H: Electro-oculogram findings in patients treated with antimalarial drugs. Br J Ophthalmol 1965;49:573-589.
8. Sverak J, Erbenova Z, Peregrin J, Salavec M: The ERG and EOG potentials after long-term Resochin therapy (in German). Klin Monatsbl Augenheilkd 1970;157:389-392.
9. Graniewski-Wijnands HS, van Lith GH, Vijfvinkel-Bruinenga S: Ophthalmological examination of patients taking chloroquine. Doc Ophthalmol 1980;48:231-234.
10. Percival SP: The ocular toxicity of chloroquine. Trans Ophthalmol Soc UK 1967;87:355-357.
11. Reijmer CN, Tijssen JG, Kok GA, van Lith GH: Interpretation of the electro-oculogram of patients taking chloroquine. Doc Ophthalmol 1980;48:273-276.
12. Van Lith GH: Electro-ophthalmology and side-effects of drugs. Doc Ophthalmol 1977;44:19-21.
13. Pinckers A, Broekhuyse RM: The EOG in rheumatoid arthritis. Acta Ophthalmol (Copenh) 1983;61:831-837.
14. Gouras P, Gunkel R: The EOG in chloroquine and other retinopathies. Arch Ophtalmol 1963;70:91-100.
15. Mazzuca SA, Yung R, Brandt KD, et al: Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy. J Rheumatol 1994;21:59-63.
16. Easterbrook M: Current concepts in monitoring patients on antimalarials. Aust N Z J Ophthalmol 1998;26:101-103.
17. Fielder A, Graham E, Jones S, et al: Royal College of Ophthalmologists guidelines: Ocular toxicity and hydroxychloroquine. Eye 1998;12:907-909.
18. Potts AM: Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest Ophthalmol 1964;3:399-404.
19. Gonasun LM, Potts AM: In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol 1974;13:107-115.
20. Leblanc B, Jezequel S, Davies T, et al: Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharmacol 1998;28:124-132.
21. Francois J, Maudgal MC: Experimental chloroquine retinopathy. Ophthalmologica 1964;148:442-452.
22. Gregory MH, Rutty DA, Wood RD: Differences in the retinotoxic action of chloroquine and phenothiazine derivatives. J Pathol 1970;102:139-150.
23. Legros J, Rosner I: Electroretinographic modifications in albino rats after chronic administration of toxic doses of hydroxychloroquine and desethylhydroxychloroquine (in French). Arch Ophtalmol Rev Gen Ophtalmol 1971;31:165-180.
24. Kuhn H, Keller P, Kovacs E, Steiger A: Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam. Graefes Arch Klin Exp Ophthalmol 1981;216:177-190.
25. Ivanina TA, Zueva MV, Lebedeva MN, et al: Ultrastructural alterations in rat and cat retina and pigment epithelium induced by chloroquine. Graefes Arch Clin Exp Ophthalmol 1983;220:32-38.
26. Ramsey MS, Fine BS: Chloroquine toxicity in the human eye: Histopathologic observations by electron microscopy. Am J Ophthalmol 1972;73:229-235.
27. Rosenthal AR, Kolb H, Bergsma D, et al: Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978;17:1158-1175.
28. Hodgkinson BJ, Kolb H: A preliminary study of the effect of chloroquine on the rat retina. Arch Ophthalmol 1970;84:509-515.
29. Arden GB: Comparison of new psychophysics and perimetry with electrophysiological techniques in the diagnosis of glaucoma. Curr Opin Ophthalmol 1993;4:14-21.
30. Cursiefen C, Grunert U, Junemann A: Chloroquine-induced bull's eye maculopathy without electrophysiologic changes (in German). Klin Monatsbl Augenheilkd 1997;210:400-401.
31. Arden G, Gunduz K, Perry S: Color vision testing with a computer graphics system: Preliminary results. Doc Ophthalmol 1988;69:167-174.
32. Gunduz K, Arden GB, Perry S, et al: Color vision defects in ocular hypertension and glaucoma: Quantification with a computer-driven color television system. Arch Ophthalmol 1988;106:929-935.
33. Berninger T, Drobner B, Hogg C, et al: Color vision in relation to age: A study of normal values (in German). Klin Monatsbl Augenheilkd 1999;215:37-42.
34. Bach M, Hawlina M, Holder GE, et al: Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 2000;101:11-18.
35. Bach M, Schumacher M: The influence of ambient room lighting on the pattern electroretinogram (PERG). Doc Ophthalmol 2002;105: 281-289.
36. Sutter EE, Tran D: The field topography of ERG components in man. I. The photopic luminance response. Vision Res 1992;32:433-446.
37. Neubauer AS, Samari-Kermani K, Schaller U, et al: Detecting chloroquine retinopathy: Electro-oculogram versus colour vision. Br J Ophthalmol 2003;87:902-908.
38. Lüllmann-Rauch R (ed): Lipoidosis of the Retina due to Cationic Amphiphilic Drugs: Rat. Berlin, Springer, 1991, pp 87-92.
39. Meier-Ruge W, Cerletti A: Zur experimentellen Pathologie der Phenothiazin-Retinopathie. Ophthalmologica 1966;151:512-533.
40. Tanenbaum L, Tuffanelli DL: Antimalarial agents: Chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol 1980;116:587-591.
41. Duncker G, Bredehorn T: Chloroquine-induced lipidosis in the rat retina: Functional and morphological changes after withdrawal of the drug. Graefes Arch Clin Exp Ophthalmol 1996;234:378-381.
42. Duncker G, Schmiederer M, Bredehorn T: Chloroquine-induced lipidosis in the rat retina: A functional and morphological study. Ophthalmologica 1995;209:79-83.
43. Kellner U, Kraus H, Foerster MH: Multifocal ERG in chloroquine retinopathy: Regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 2000;238:94-97.
44. Wolfelschneider P, Kohen L, Wiedemann P: Maculopathy in long-term chloroquine therapy (in German). Ophthalmologe 1998;95:186-187.
45. Okun E, Gouras P, Bernstein HN, von Sallmann L: Chloroquine retinopathy: A report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol 1963;58:774-778.
46. Nozik RA, Weinstock FJ, Vignos PJ: Ocular complications of chloroquine: A series and case presentation with a simple method for early detection of retinopathy. Am J Ophthalmol 1964;58:774-778.
47. Carr RE, Gouras P, Gunkel RD: Chloroquine retinopathy: Early detection by retinal threshold test. Arch Ophthalmol 1966;75:171-178.
48. Henkind P, Carr RE, Siegel IM: Early chloroquine retinopathy: Clinical and functional findings. Arch Ophthalmol 1964;71:157-165.
49. Nylander U: Ocular damage in chloroquine therapy. Acta Ophthalmol (Copenh) 1966;44:335-348.
50. Percival SP, Meanock I: Chloroquine: Ophthalmological safety, and clinical assessment in rheumatoid arthritis. Br Med J 1968;iii:579-584.
51. Bartel PR, Roux P, Robinson E, et al: Visual function and long-term chloroquine treatment. S Afr Med J 1994;84:32-34.
52. Easterbrook M: Ocular effects and safety of antimalarial agents. Am J Med 1988;85:23-29.
53. Jaeger W: Acquired colour-vision deficiencies caused by side-effects of pharmacotherapy (in German). Klin Monatsbl Augenheilkd 1977; 170:453-460.
54. Grutzner P: Acquired color vision defects secondary to retinal drug toxicity. Ophthalmologica 1969;158(suppl):592-604.
55. Easterbrook M: The ocular safety of hydroxychloroquine. Semin Arthritis Rheum 1993;23:62-67.
56. Percival SP, Behrman J: Ophthalmological safety of chloroquine. Br J Ophthalmol 1969;53:101-109.
57. Niemeyer G, Fruh B: Examination strategies in the diagnosis of drug-induced retinal damage (in German). Klin Monatsbl Augenheilkd 1989;194:355-358.
58. Easterbrook M: Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 1999;39:49-57.
59. Curcio CA, Allen KA: Topography of ganglion cells in human retina. J Comp Neurol 1990;300:5-25.
60. Weiter JJ, Delori FC, Wing GL, Fitch KA: Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 1986;27:145-152.
61. Dorey CK, Wu G, Ebenstein D, et al: Cell loss in the aging retina: Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 1989;30:1691-1699.
62. Gerling J, Geiger K, Bach M: Atrophy of the ganglion cells reduces pattern ERG not only in fine but also in coarse test patterns (in German). Fortschr Ophthalmol 1991;88:833-837.